A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2004
12/15/2004	EP1486495A1 Lipoic acid derivatives and their use in treatment of disease
12/15/2004	EP1486494A1 N-substituted benzothiophenesulfonamide derivative
12/15/2004	EP1486488A1 Use of a compound of formula I for making a pharmaceutical composition
12/15/2004	EP1486216A1 Method of encapsulating metal complex within liposomes
12/15/2004	EP1486211A1 Compositions for treating cancer using viruses
12/15/2004	EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1485719A2 Peptide epitopes common to antigens of the same multigene family
12/15/2004	EP1485492A2 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants
12/15/2004	EP1485488A2 Recombinant negative strand virus rna expression systems and vaccines
12/15/2004	EP1485476A2 Dimeric tf antagonist
12/15/2004	EP1485472A2 Crystal structure of an aurora kinase catalytic domain, and uses thereof
12/15/2004	EP1485469A2 Virus like particle from papillomavirus and their use in vaccine
12/15/2004	EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
12/15/2004	EP1485466A2 Methods for treating diseases or conditions with peptide constructs
12/15/2004	EP1485415A2 Neoplasm specific antibodies and uses thereof
12/15/2004	EP1485413A2 Biologically active complex
12/15/2004	EP1485396A2 Nucleoside 5'-monophosphate mimics and their prodrugs
12/15/2004	EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485378A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485377A1 Pyranones useful as atm inhibitors
12/15/2004	EP1485376A1 Compositions useful as inhibitors of protein kinases
12/15/2004	EP1485375A1 Pyrimidine compounds
12/15/2004	EP1485374A1 Pyrimidine compounds
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485368A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004	EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485347A2 Hif hydroxylase inhibitors
12/15/2004	EP1485345A2 Urokinase inhibitors, production and use thereof
12/15/2004	EP1485168A1 Combination of a cdk inhibitor and 5-fu for the treatment of cancer
12/15/2004	EP1485160A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
12/15/2004	EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
12/15/2004	EP1485131A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
12/15/2004	EP1485130A2 Reagents and treatment methods for autoimmune diseases
12/15/2004	EP1485125A1 Improvements in vaccination
12/15/2004	EP1485116A2 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
12/15/2004	EP1485114A2 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
12/15/2004	EP1485109A1 Vascular therapeutics
12/15/2004	EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
12/15/2004	EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
12/15/2004	EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
12/15/2004	EP1485092A1 Use of rapamycin for inhibiting of cell death
12/15/2004	EP1485090A2 Combinations comprising epothilone derivatives and alkylating agents
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
12/15/2004	EP1485087A1 (+)-2- 1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
12/15/2004	EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/15/2004	EP1485078A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
12/15/2004	EP1485076A1 Therapeutic methods for acute myeloid leukemia
12/15/2004	EP1485075A2 Mhc-peptide complex binding ligands
12/15/2004	EP1430033A4 Anti-inflammatory and protein kinase inhibitor composition and method of use
12/15/2004	EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004	EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
12/15/2004	EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists
12/15/2004	EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients
12/15/2004	EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof
12/15/2004	EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/15/2004	EP1301517B1 Thienopyrrolidinones
12/15/2004	EP1263779B1 Self antigen vaccines for treating b cell lymphomas and other cancers
12/15/2004	EP1259248B1 Methods for treating cancers expressing vascular endothelial growth factor d
12/15/2004	EP1226160B1 Novel antiarrhythmic peptides
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	EP1226125B1 Method for producing therapeutic agents for ulcers
12/15/2004	EP1218005B1 Vitronectin receptor antagonists
12/15/2004	EP1149063B1 Ureido-thiobutyric acid derivatives as ppar-agonists
12/15/2004	EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
12/15/2004	EP1017283B1 Polynucleotide vaccine formulations
12/15/2004	EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies
12/15/2004	EP0884051B1 Cancerous metastasis inhibitors containing uracil derivatives
12/15/2004	EP0788507B1 L-pyranosyl nucleosides
12/15/2004	EP0773996B1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF
12/15/2004	CN1555488A Lymphatic endothelial cells materials and methods
12/15/2004	CN1555487A A process for the isolation of a major harmful oxidant from cigarette smoke
12/15/2004	CN1555411A Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
12/15/2004	CN1555367A 3-substituted-4-pyrimidone derivatives
12/15/2004	CN1555365A N-aminoimidazole derivative for inhibiting HIV
12/15/2004	CN1555359A Alkyl urea vitamin A protagonist i
12/15/2004	CN1555357A Substituied ureaalkyl urea vitamin A protagonist ii
12/15/2004	CN1555356A Bisphenol derivative as NHE-3 inhibitor
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations
12/15/2004	CN1555272A Compositions and methods for modulation of immune responses
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier
12/15/2004	CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity
12/15/2004	CN1555253A Oily composition of taxol,preparation for chemical therapeutic embolism and their producing method
12/15/2004	CN1554774A Use of Ard1 gene in mammary cancer diagnosis and treatment
12/15/2004	CN1554659A Synthetic method for natural product Epsilon B lactam derivative
12/15/2004	CN1554444A Endothelial cell proliferation inhibitor and method of use

1 ... 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 ... 2211